These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 21926995

  • 1. Ligand discovery from a dopamine D3 receptor homology model and crystal structure.
    Carlsson J, Coleman RG, Setola V, Irwin JJ, Fan H, Schlessinger A, Sali A, Roth BL, Shoichet BK.
    Nat Chem Biol; 2011 Sep 18; 7(11):769-78. PubMed ID: 21926995
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Critical analysis of the successes and failures of homology models of G protein-coupled receptors.
    Bhattacharya S, Lam AR, Li H, Balaraman G, Niesen MJ, Vaidehi N.
    Proteins; 2013 May 18; 81(5):729-39. PubMed ID: 23042299
    [Abstract] [Full Text] [Related]

  • 4. Progress in the structural prediction of G protein-coupled receptors: D3 receptor in complex with eticlopride.
    Obiol-Pardo C, López L, Pastor M, Selent J.
    Proteins; 2011 Jun 18; 79(6):1695-703. PubMed ID: 21491496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists.
    Furman CA, Roof RA, Moritz AE, Miller BN, Doyle TB, Free RB, Banala AK, Paul NM, Kumar V, Sibley CD, Newman AH, Sibley DR.
    Eur Neuropsychopharmacol; 2015 Sep 18; 25(9):1448-61. PubMed ID: 25583363
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.
    Li A, Mishra Y, Malik M, Wang Q, Li S, Taylor M, Reichert DE, Luedtke RR, Mach RH.
    Bioorg Med Chem; 2013 Jun 01; 21(11):2988-98. PubMed ID: 23618707
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.
    Ananthan S, Saini SK, Zhou G, Hobrath JV, Padmalayam I, Zhai L, Bostwick JR, Antonio T, Reith ME, McDowell S, Cho E, McAleer L, Taylor M, Luedtke RR.
    J Med Chem; 2014 Aug 28; 57(16):7042-60. PubMed ID: 25126833
    [Abstract] [Full Text] [Related]

  • 9. Two Binding Geometries for Risperidone in Dopamine D3 Receptors: Insights on the Fast-Off Mechanism through Docking, Quantum Biochemistry, and Molecular Dynamics Simulations.
    Zanatta G, Della Flora Nunes G, Bezerra EM, da Costa RF, Martins A, Caetano EW, Freire VN, Gottfried C.
    ACS Chem Neurosci; 2016 Oct 19; 7(10):1331-1347. PubMed ID: 27434874
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Parallel synthesis and biological screening of dopamine receptor ligands taking advantage of a click chemistry based BAL linker.
    Bettinetti L, Löber S, Hübner H, Gmeiner P.
    J Comb Chem; 2005 Oct 19; 7(2):309-16. PubMed ID: 15762761
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Beyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug design.
    Keck TM, Burzynski C, Shi L, Newman AH.
    Adv Pharmacol; 2014 Oct 19; 69():267-300. PubMed ID: 24484980
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands.
    Elek M, Djokovic N, Frank A, Oljacic S, Zivkovic A, Nikolic K, Stark H.
    Arch Pharm (Weinheim); 2021 Jun 19; 354(6):e2000486. PubMed ID: 33615541
    [Abstract] [Full Text] [Related]

  • 16. Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling.
    Hobrath JV, Wang S.
    J Med Chem; 2006 Jul 27; 49(15):4470-6. PubMed ID: 16854052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ligand Discovery for a Peptide-Binding GPCR by Structure-Based Screening of Fragment- and Lead-Like Chemical Libraries.
    Ranganathan A, Heine P, Rudling A, Plückthun A, Kummer L, Carlsson J.
    ACS Chem Biol; 2017 Mar 17; 12(3):735-745. PubMed ID: 28032980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.